Novartis researchers tackle sensory deficits and frailty as the global population grows older.
Targeting STING could aid immune system attacks on cancer. See how it might protect against further cancer growth and metastisis.
Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.